SubHero Banner
Text

January 2023

Core topics in this month’s edition include:

  • Leqembi (lecanemab-irmb) – new drug approval
  • Liptruzet (atorvastatin/ezetimibe) – first time generic
  • Global Strategy for Prevention, Diagnosis and Management of Chronic Obstructive Pulmonary Disease – 2023 Report

Download PDF

Text